The Combination of icariin and constrained dynamic loading stimulation attenuates bone loss in ovariectomy‐induced osteoporotic mice
- 23 October 2017
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 36 (5) , 1415-1424
Abstract
Osteoporosis is a disease characterized by low bone mass and progressive destruction of bone microstructure, resulting in increasing the risk of fracture. Icariin (ICA) as a phytoestrogen shows osteogenic effects, and the mechanical stimulation has been demonstrated the improving effect on osteoporosis. The objective of this study was to investigate the effect of ICA in combination with constrained dynamic loading (CDL) stimulation on osteoporosis in ovariectomized (OVX) mice. The serum hormone levels, bone turnover markers, trabecular architecture, ulnar biomechanical properties, and the expression of osteoblast‐related gene (alkaline phosphatase, ALP; osteocalcin, OCN; bone morphogenetic protein‐2, BMP‐2; Collagen I (α1), COL1; osteoprotegerin, OPG) and osteoclast‐related genes (receptor activators of NF‐κB ligand, RANKL; tartrate‐resistant acid phosphatase, TRAP) were analyzed. The results showed that ICA + CDL treatment could increase the osteocalcin (20.85%), estradiol levels (20.61%) and decrease the TRAP activity (26.27%) significantly than CDL treatment. The combined treatment attenuated bone loss and biomechanical decrease more than single use of CDL treatment. ICA + CDL treatment significantly up‐regulated the level of osteoblast‐related gene expression and down‐regulated the osteoclast‐related genes expression; moreover, the combined treatment increased the ratio of OPG/RANKL significantly compared to ICA (72.83%) or CDL (65.63%) treatment alone. The present study demonstrates that icariin in combination with constrained dynamic loading treatment may have a therapeutic advantage over constrained dynamic loading treatment alone for the treatment of osteoporosis, which would provide new evidence for the clinical treatment of osteoporosis. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1415–1424, 2018.Keywords
Funding Information
- National Natural Science Foundation of China (31500761, 31470935)
This publication has 41 references indexed in Scilit:
- Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/β-catenin pathwayExperimental and Therapeutic Medicine, 2016
- Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activationEuropean Journal of Pharmacology, 2013
- The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosisOsteoporosis International, 2011
- Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE2 synthesisPhytomedicine, 2011
- Height loss in elderly women is preceded by osteoporosis and is associated with digestive problems and urinary incontinenceOsteoporosis International, 2009
- Epimedium-Derived Phytoestrogen Flavonoids Exert Beneficial Effect on Preventing Bone Loss in Late Postmenopausal Women: A 24-Month Randomized, Double-Blind and Placebo-Controlled TrialJournal of Bone and Mineral Research, 2007
- Pathogenesis of osteoporosis: concepts, conflicts, and prospectsJournal of Clinical Investigation, 2005
- PHYTOESTROGENSAnnual Review of Plant Biology, 2004
- Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical PracticeNew England Journal of Medicine, 2003
- Bone Resorption by OsteoclastsScience, 2000